A phase 3, Randomised,double-blind, controlled study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects with Cystic: Vertex Study Number : VX20-121-103

Project Details

StatusActive
Effective start/end date19/08/2119/09/25

Funding

  • Vertex Pharmaceuticals (Aust) Pty Ltd